Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,926
Closed -$319K 120
2023
Q2
$319K Hold
5,926
﹤0.01% 109
2023
Q1
$322K Buy
5,926
+82
+1% +$3.99K ﹤0.01% 108
2022
Q4
$283K Buy
5,844
+6
+0.1% +$263 ﹤0.01% 110
2022
Q3
$222K Buy
5,838
+453
+8% +$20.2K ﹤0.01% 107
2022
Q2
$269K Hold
5,385
﹤0.01% 103
2022
Q1
$276K Hold
5,385
﹤0.01% 104
2021
Q4
$270K Sell
5,385
-50
-0.9% -$2.47K ﹤0.01% 103
2021
Q3
$262K Hold
5,435
﹤0.01% 109
2021
Q2
$286K Hold
5,435
﹤0.01% 105
2021
Q1
$269K Buy
+5,435
New +$261K ﹤0.01% 133
2018
Q3
Sell
-17,790
Closed -$712K 157
2018
Q2
$712K Hold
17,790
0.01% 156
2018
Q1
$713K Hold
17,790
0.01% 160
2017
Q4
$765K Hold
17,790
0.01% 169
2017
Q3
$886K Hold
17,790
0.01% 173
2017
Q2
$852K Sell
17,790
-4
-0% -$191 0.01% 180
2017
Q1
$805K Buy
+17,794
New +$755K 0.01% 180

Other funds holding SNY

John Rogers's SNY Position: Q3 2023 in Review

John Rogers sold out of Sanofi (SNY) in Q3 2023, closing a stake of 5,926 shares — an estimated $319K sold.

John Rogers first reported a position in SNY in Q1 2017 and held it in 16 quarters. The position peaked at $886K in Q3 2017. 697 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • John Rogers reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • John Rogers sold 5,926 Sanofi shares in Q3 2023, an estimated $319K.
  • John Rogers first reported a position in Sanofi in Q1 2017 and held it in 16 quarters.
  • John Rogers's Sanofi position peaked at $886K in Q3 2017.
  • 697 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Ariel Investments's 13F filing for Q3 2023, filed 14 Nov 2023.